Metaplastic Clinical Trials
ClinicalTrials.gov is a registry and results database of publicly and privately supported clinical trials and studies of human participants conducted around the world. Below is a link for you to search and educate yourself to any possible treatment options for metaplastic breast cancer for you to address with your oncologist. https://clinicaltrials.gov/
Clinical Trials for Metaplastic Breast Cancer
| Approval Dates | Location | Type | Phase | Criteria/Contacts |
|---|---|---|---|---|
| 1/1/2023 to 12/2028 | Houston Methodist Neal Cancer Center | Type: Alpelisib With iNOS Inhibitor and Nab-paclitaxel in Patients With HER2 Negative Metastatic or Locally Advanced Metaplastic Breast Cancer | Phase 2 | Link |
| 11/2019 to 10/2027 | LOCATIONS | DART: DUAL ANTI-CLA-4 AND ANTI- PD1 BLOCKADE IN RARE TUMORS- INTERVENTIONAL | Phase 2 | Link |
| 11/2015 to 11/2023 | UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER- HOUSTON, TX | ARTEMIS TRIAL- INTERVENTIONAL | Link | |
| 1/2016-12/2022 | UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER- HOUSTON, TX | TARGETED THERAPY | Phase 2 - no longer recruiting | Link Link |
We are aware of the challenges cancer patients endure while being enrolled in a clinical trial. We have partnered with Lazarex to provide those diagnosed with metaplastic breast cancer support with travel and lodging expenses if they are enrolled in an FDA-approved clinical trial.
For more information email us at: admin@mpbcalliance.org.